Literature DB >> 12924614

Heparin-induced extracorporeal low-density lipoprotein precipitation.

Klaus-Peter Mellwig1.   

Abstract

Heparin-induced extracorporeal low-density lipoprotein (LDL) precipitation (HELP) is a selective and careful apheresis procedure. Through the application of heparin and lowering the pH value, lipoproteins and fibrinogen are reduced by 50-60%. In addition, adhesion molecules (ICAM-1, VCAM-1, p-selectin) which play a key role in the development and progression of atherosclerosis, are also markedly reduced. A PET scan performed 20 h after LDL apheresis shows the improvement of coronary vasodilation capacity. This is supposed to be mainly due to the marked reduction of LDL cholesterol and fibrinogen with consecutive improvement of endothelial dysfunction and rheology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12924614     DOI: 10.1046/j.1526-0968.2003.00051.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  5 in total

1.  Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.

Authors:  Gianpaolo Russi; Luciana Furci; Marco Leonelli; Riccardo Magistroni; Nicola Romano; Paolo Rivasi; Alberto Albertazzi
Journal:  J Med Case Rep       Date:  2009-12-02

2.  Low-density lipoprotein apheresis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-11-01

3.  HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures.

Authors:  Frank van Buuren; Sven Kreickmann; Dieter Horstkotte; Tanja Kottmann; Klaus Peter Mellwig
Journal:  Clin Res Cardiol Suppl       Date:  2012-06

Review 4.  Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.

Authors:  Eduardo Cambruzzi; Karla Lais Pêgas
Journal:  J Bras Nefrol       Date:  2018-11-08

Review 5.  Update on Clinical Trials in Dry Age-related Macular Degeneration.

Authors:  Ibrahim Taskintuna; M E A Abdalla Elsayed; Patrik Schatz
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.